Skip to content
Search

Latest Stories

GPhC considers annual monitoring of all pharmacy education providers

GPhC considers annual monitoring of all pharmacy education providers

The regulator proposes four key changes to the quality assurance of pharmacy education

The General Pharmaceutical Council (GPhC) has launched a consultation on changes to the quality assurance processes of pharmacy education and training.


In its consultation published on 4 April 2024, the pharmacy regulator has proposed four key changes to the procedures, including annual monitoring of all pharmacy education providers, including pharmacy schools offering MPharm courses.

The annual audit will enable the GPhC “to identify and address concerns together with providers in a more timely, proportionate and systematic manner”.

It is considering collecting yearly data, including feedback from students, trainees, supervisors and patients, from educational organisations.

The GPhC has also proposed defining clear lines of responsibility and criteria for determining whether to re-approve a course or qualification.

Other suggestions put forth include increasing flexibility for approval and intervention, alongside implementing uniform arrangements for all providers to achieve greater scrutiny.

The consultation states: “We propose to apply to private providers and pharmacist independent prescribing providers the same arrangements that apply to national awarding organisations and MPharm providers.

“In effect, this will result not only in greater scrutiny but in a consistent quality assurance approach overall.”

Mark Voce, chief strategy officer and deputy registrar at the GPhC, said: “Pharmacy education and training sets a foundation for the knowledge, skills, understanding and professional behaviours a pharmacy student must demonstrate in order to become fully qualified and join the professional register.

“As such it is vital that we check that training providers are meeting our standards through a quality assurance process. By doing this we are ensuring trainees are getting the right level of education to become competent practitioners of the future.”

He added that the proposed changes will help them “identify issues more effectively, act more quickly if necessary and be fairer to all providers.”

The QA process also ensures that pharmacists and pharmacy technicians joining the register are “skilled and knowledgeable, and that they demonstrate appropriate professional behaviours.”

Individuals and organisations with an interest in pharmacy education are being encouraged to take part in the consultation, which closes on 13 June 2024.

Depending on the outcome of the consultation, the regulator plans to implement these changes in stages over the coming years.

More For You

Pharmacist handing medicine to patient, NHS prescription cost freeze debate

Prescription charge will remain at £9.90

Pic credit: iStock

NPA calls for end to prescription charge after freeze announcement

The National Pharmacy Association (NPA) has asked for prescription charges to be completely removed despite the government announcing today that the charge will be frozen for the first time in three years.

Patients will continue paying £9.90 to collect their medication from a pharmacy.

Keep ReadingShow less
RPS launches new prescribing development programme for pharmacists

From 2026, every newly qualified pharmacist will be an independent prescriber

gettyimages

RPS unveils new training programme to enhance pharmacists’ prescribing skills

The Royal Pharmaceutical Society (RPS) has announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

The initiative comes ahead of the NHS mandate that every newly qualified pharmacist will be an independent prescriber by 2026 — a change set to transform the future of pharmacy practice.

Keep ReadingShow less
Varenicline promotes nicotine vaping cessation in young people

Researchers warn that e-cigarette use can increase risk for nicotine addiction,uptake of combusted tobacco and other substance use.

gettyimages

Anti-smoking pill varenicline may help young people quit vaping, new study suggests

Varenicline — a daily pill already offered through NHS Stop Smoking Services — could also support young people in quitting vaping, new research has suggested.

The medication, proven to be more effective than nicotine replacement gums or patches for smoking cessation, was shown to significantly boost vaping abstinence when combined with behavioural counselling in adolescents and young adults.

Keep ReadingShow less
Relying on blue inhalers alone can worsen asthma symptoms, warns MHRA

Patients are advised to use their preventer inhaler regularly, even if their asthma feels under control.

Pic credit: gettyimages

Overuse of blue inhalers can increase risk of severe asthma attacks, warns MHRA

The Medicines and Healthcare products Regulatory Agency (MHRA) is reminding asthma patients to use their preventer (anti-inflammatory) inhalers regularly as prescribed, rather than relying solely on their blue inhalers, also referred to as reliever inhalers.

“Without regular use of a preventer inhaler, symptoms could worsen and increase the risk of severe asthma attacks,” the MHRA warned.

Keep ReadingShow less
13 pharmacists achieve RPS core advanced credential with record pass rate

The latest successful cohort includes pharmacists from both England and Scotland.

Pic credit: Getty Images

13 more pharmacists achieve RPS core advanced credential - Highest pass rate yet

The Royal Pharmaceutical Society (RPS) has announced that 13 more pharmacists have successfully completed Core Advanced Credentialling as part of the latest assessment cohort —achieving a remarkable 93% pass rate, the highest to date.

This brings the total number of pharmacists awarded the RPS core advanced credential to 113 since the launch of the Core Advanced Curriculum in 2023, with successful candidates from GP, secondary care and community settings.

Keep ReadingShow less